Melissa Weinberg is an Endocrinology/Metabolic physician affiliated with California Pacific Medical Center. OpenAlex indexes 10 publications with 702 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1375 Sutter St Ste 208
San Francisco, CA 94109
Telephone
415-600-0110Registry record last updated 7 Mar 2023.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dexcom, Inc.Program year20241 payment
- SANOFI-AVENTIS U.S. LLCProgram year20231 payment
- Horizon Therapeutics plcProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
60.6%GLP-1 receptor agonist18.6%Ozempic61%Trulicity19%Mounjaro16%Rybelsus4%Part D<11 patientsBiguanide (metformin)12.2%Metformin Hcl Er66%Metformin Hcl35%Part D≥36 patients+ 4 more classes in this area
Hormonal (systemic)
22.4%l-Thyroxine19%Levothyroxine Sodium68%Synthroid29%Tirosint4%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.7%Methimazole100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
17%Statin9.5%Atorvastatin Calcium82%Rosuvastatin Calcium18%Part D<11 patientsAngiotensin receptor blocker (ARB)4%Losartan Potassium81%Irbesartan19%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Journal of Diabetes Science and Technology
2022 - SUN-007 Elevated Levothyroxine Requirements Post-Partum as Initial Presentation of Placenta Accreta
Journal of the Endocrine Society
2020 - Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat
The Journal of Clinical Endocrinology & Metabolism
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Emmett Cunningham, MD, PhD, MPH
California Pacific Medical Center
John Chan, MD
California Pacific Medical Center
Kenneth Binmoeller, MD
California Pacific Medical Center
Yvonne Cheng, MD
California Pacific Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”